Phapros (PEHA) Distributes Rp 3.980 Billion MSE Funding Program in 2024

Semarang, December 18, 2024 - PT Phapros Tbk (PEHA), a subsidiary of PT Kimia Farma Tbk (KAEF), once again distributed the Micro and Small Enterprise (MSE) Funding Program Phase IV/2024 to 20 prospective fostered partners at the Simongan office, Semarang, Central Java.

The MSE funding program is a form of Phapros' commitment to develop the ability of small businesses to be more independent, able to encourage economic growth so as to create a sense of equitable development and increase / expansion of employment in the region. Corporate Secretary of PT Phapros Tbk,

Zahmilia Akbar, who was present virtually, congratulated the 20 MSME players who were selected to become Phapros' fostered partners and were proud for having the courage to make the decision to become Indonesian MSME players. “As is known during the covid period, Indonesian MSMEs grew bigger than the manufacturing industry. In 2024 alone, MSMEs are predicted to grow around 6-7%. As for the contribution of Indonesia's Gross Domestic Product (GDP), almost 60% is contributed by MSME players, “he continued.

In this last stage of disbursement, Phapros will distribute revolving funds amounting to Rp 1,340,000,000 (one billion three hundred forty million rupiah) to 20 prospective fostered partners. For information, the total revolving funds that have been distributed by Phapros in 2024 amounted to Rp 3,980,000,000 (three billion nine hundred eighty million rupiah) with a total of 63 fostered partners, including 27 old partners and 36 new partners spread across Indonesia. At the end of the speech, Zahmilia advised all fostered partners that in the future there will be joint sustainability between Phapros and its fostered partners, such as monitoring, training, exhibitions, and other collaborations.